Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation.

Cancers (Basel) · 2022 · PMC9101696 · PMID 35565184

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Though the data did not reach statistical significance, they found a trend of overall survival at 13.9 months versus 10.6 months for the placebo, and felt that the trial demonstrated a favorable risk-to-benefit profile.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.